Association of baseline big endothelin-1 level with long-term prognosis among cardiac resynchronization therapy recipients

Baseline big ET-1 > 0.56 pmol/L was independently associated with higher all-cause mortality and HFH among CRT recipients, and therefore can be added to the marker panel used for stratifying high risk CRT patients for priority treatment.